Drugmakers applaud accelerated approvals

Patients to benefit as breakthroughs take less time to come to market, while increased competition helps to lower costs

China is approving foreign drugs at a record speed, which industry sources said shows the country's commitment to further opening up its healthcare sector and supporting innovation.

Since 2016, the country has adopted a series of policy amendments to speed up new drug approvals, as part of its widespread reforms in healthcare, opening-up, and improving market access.